Today: 16 May 2026
Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up
12 April 2026
2 mins read

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

NEW YORK, April 12, 2026, 04:11 EDT

Bitcoin fell back Sunday, handing over a chunk of its recent gains as U.S.-Iran negotiations in Islamabad wrapped up with no agreement. The largest cryptocurrency hovered at $71,707, off roughly 1.4% from its last close, after climbing to as high as $73,744 earlier in the session.

This shift is notable, with bitcoin barely regaining the $70,000 handle as traders pinned hopes on a tentative truce to calm oil and stabilize wider markets. Now, that bounce is under pressure again—war news, inflation prints, and fast-moving fund flows all back in play.

Money kept moving into U.S. spot bitcoin ETFs—these are funds pegged directly to the token itself. On April 9, the group took in $358.1 million, with another $240.4 million flowing in on April 10. That followed back-to-back outflows on April 7 and April 8. BlackRock’s IBIT and Fidelity’s FBTC pulled in the largest share of Friday’s action.

Morgan Stanley’s MSBT fund is pushing further into the institutional space. The Wall Street bank kicked off its ETF on April 8, marking the first time a major U.S. bank launched a Bitcoin-linked product. Bloomberg noted the spot-bitcoin ETF market is now above $85 billion in assets. Eric Balchunas at Bloomberg Intelligence pointed to MSBT’s “aggressive fee positioning,” calling it a clear sign that financial advisers are hungry for the product. Morgan Stanley

On Friday, U.S. inflation numbers left crypto traders with an uneven picture. Headline CPI jumped 3.3% in March—marking the quickest annual increase since 2022. But core CPI, which excludes food and energy to better gauge underlying trends, landed at 2.6%, undershooting forecasts.

That’s part of the reason bitcoin managed to hang onto most of its gains this week, even after diplomatic efforts over the weekend fizzled out. Earlier, Reuters market reports showed the token surging past $71,000 following the U.S.-Iran ceasefire that boosted risk assets—markets like crypto and tech stocks, which tend to climb when risk appetite rises.

Ether slipped too, changing hands at $2,218.67 as of this day. Capital kept finding its way to the larger, established funds, despite prices once again hitting turbulence.

Executives at Morgan Stanley aren’t mincing words about demand. Amy Oldenburg, who leads digital-asset strategy at the bank, told Bloomberg Markets that MSBT marked the firm’s “best-ever launch.” From the ETF side, Allyson Wallace—global head—said interest from high-net-worth clients has been “quite high.” Bloomberg

The rebound isn’t convincing investors yet. After 21 hours, negotiators in Islamabad walked away without a deal. March inflation numbers jumped, driven by an energy surge linked to the Iran conflict. Saudi Arabia reported full East-West pipeline capacity restored on Sunday, but regional shipping threats remain unresolved.

Bitcoin’s rebound hasn’t closed the gap: it’s still trading roughly 43% beneath that all-time peak of $125,835.92 from October. There’s a tug of war here. One side: consistent institutional buying. The other: a macro environment that could sour fast—oil, inflation, geopolitics all in the mix.

Stock Market Today

  • Synergy CHC Files S-1 for Resale and $36M Equity Line
    May 15, 2026, 6:07 PM EDT. Synergy CHC Corp. filed a Form S-1 registration with the U.S. Securities and Exchange Commission on May 15, 2026, for a proposed resale of securities and a $36 million equity line of credit. The filing, under the Securities Act of 1933, aims to facilitate the company's ability to raise capital through public offerings on a delayed or continuous basis as permitted by Rule 415. Synergy CHC, incorporated in Nevada and headquartered in Maine, is classified as a non-accelerated filer, reflecting smaller market capitalization. The equity line is expected to provide liquidity and support the company's growth initiatives, with offerings commencing once the registration becomes effective.

Latest articles

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT delays annual meeting to June after AI-driven stock jump

AXT delays annual meeting to June after AI-driven stock jump

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 12.04.2026

Palantir Technologies (PLTR) Stock Rebounds After Cathie Wood Buys the Dip, but AI Rival Fears Linger
Next Story

Palantir Technologies (PLTR) Stock Rebounds After Cathie Wood Buys the Dip, but AI Rival Fears Linger

Go toTop